This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 14 print issues and online access
$259.00 per year
only $18.50 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kunal, G. et al. Population pharmacokinetics of ciprofloxacin in newborns with early onset neonatal sepsis and suspected meningitis. Pediatr. Res. https://doi.org/10.1038/s41390-023-02941-3 (2023).
Lim, S. Y., May, C. B., Johnson, P. N. & Miller, J. L. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. Pediatr. Res. 93, 696–700 (2023).
Flint, R. B. et al. The bioavailability and maturing clearance of doxapram in preterm infants. Pediatr. Res. 89, 1268–1277 (2021).
Frymoyer, A. et al. Theophylline dosing and pharmacokinetics for renal protection in neonates with hypoxic-ischemic encephalopathy undergoing therapeutic hypothermia. Pediatr. Res. 88, 871–877 (2020).
Ward, R. M. et al. Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates. Pediatr. Res. 81, 692–711 (2017).
Schouwenburg, S. et al. Review of scavenged sampling for sustainable therapeutic drug monitoring: do more with less. Ther. Drug Monit. 44, 215–223 (2022).
De Cock, R. F. et al. A neonatal amikacin covariate model can be used to predict ontogeny of other drugs eliminated through glomerular filtration in neonates. Pharm. Res. 31, 754–767 (2014).
Zhao, W. et al. External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings. Br. J. Clin. Pharm. 75, 1068–1080 (2013).
Allegaert, K. et al. Covariates of tramadol disposition in the first months of life. Br. J. Anaesth. 100, 525–532 (2008).
Mahoney, L. et al. Grading the level of evidence of neonatal pharmacotherapy: midazolam and phenobarbital as examples. Pediatr. Res. https://doi.org/10.1038/s41390-023-02779-9 (2023).
Acknowledgements
Besides the affiliations mentioned, Karel Allegaert is appointed as Honorary Guest Professor at Henan, Zhengzhou Children’s Hospital (2023–2028).
Author information
Authors and Affiliations
Contributions
Both authors contributed to the commentary and agreed on the final version of the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Y., Allegaert, K. Why population pharmacokinetic studies are instrumental to boost clinical research in neonates, and suggestions on how clinicians should assess these papers. Pediatr Res 95, 1181–1183 (2024). https://doi.org/10.1038/s41390-023-03011-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41390-023-03011-4